| scholarly article | Q13442814 |
| P2093 | author name string | Arvin AM | |
| Yeager AS | |||
| Urbani LJ | |||
| Kemp JA 3rd | |||
| P2860 | cites work | Antibody-dependent cellular protection against herpes simplex virus dissemination as revealed by viral plauqe and infectivity assays | Q40072912 |
| Cellular Immune Response in Genital Herpes Simplex Virus Infection | Q40173139 | ||
| Antibody-mediated recovery from subcutaneous herpes simplex virus type 2 infection | Q40911362 | ||
| Measurement of antibodies to herpesvirus types 1 and 2 in human sera | Q43654478 | ||
| Perinatal risk associated with maternal genital herpes simplex virus infection | Q45821590 | ||
| Hepres genitalis; clinical and cytopathologic experience with 256 patients | Q52740851 | ||
| Human neonatal and maternal monocyte-macrophage and lymphocyte-mediated antibody-dependent cytotoxicity to cells infected with herpes simplex | Q67356543 | ||
| Herpes genitalis: clinical features | Q68654830 | ||
| Clinical and virologic course of herpes simplex genitalis | Q34052511 | ||
| Type specificity of complement-requiring and immunoglobulin M neutralizing antibody in initial herpes simplex virus infections of humans | Q34128006 | ||
| Passive immunization in experimental Herpesvirus hominis infection of newborn mice | Q34131920 | ||
| Lymphocyte transformation and interferon production in human mononuclear cell microcultures for assay of cellular immunity to herpes simplex virus | Q34399029 | ||
| Prevention of cell-to-cell spread of herpes simplex virus by leukocytes | Q36272383 | ||
| Antiviral chemotherapy and neonatal herpes simplex virus infecition: a pilot study--experience with adenine arabinoside (ARA-A) | Q39929711 | ||
| Synergistic Antiviral Effects of Adenine Arabinoside and Humoral Antibodies in Experimental Encephalitis Due to Herpesvirus hominis | Q39968669 | ||
| Genital Herpetic Infection in Men and Women: Clinical Course and Effect of Topical Application of Adenine Arabinoside | Q39996562 | ||
| Postexposure serum prophylaxis of neonatal herpes simplex virus infection of mice | Q39997583 | ||
| Antibody-dependent cellular cytotoxicity to target cells infected with herpes simplex viruses: functional adequacy in the neonate | Q40052681 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Neonatal herpes simplex | Q3134326 |
| P304 | page(s) | 532-538 | |
| P577 | publication date | 1980-08-01 | |
| P1433 | published in | Infection and Immunity | Q6029193 |
| P1476 | title | Relationship of antibody to outcome in neonatal herpes simplex virus infections | |
| P478 | volume | 29 |
| Q34256508 | Analysis of the role of antibody-dependent cellular cytotoxic antibody activity in murine neonatal herpes simplex virus infection with antibodies to synthetic peptides of glycoprotein D and monoclonal antibodies to glycoprotein B |
| Q36432263 | Antibody responses in humans to individual proteins of herpes simplex viruses |
| Q31998570 | Characterization of a type-common human recombinant monoclonal antibody to herpes simplex virus with high therapeutic potential. |
| Q37110812 | Detection of type-specific antibody to herpes simplex virus type 1 by radioimmunoassay with herpes simplex virus type 1 glycoprotein C purified with monoclonal antibody |
| Q58609061 | Development of disease and immunity at the genital epithelium following intrarectal inoculation of male guinea pigs with herpes simplex virus type 2 |
| Q45828020 | Disseminated neonatal herpes simplex virus infection acquired from the father |
| Q36568824 | Guidance on management of asymptomatic neonates born to women with active genital herpes lesions |
| Q36699405 | Herpes simplex virus infections of the central nervous system. Encephalitis and neonatal herpes |
| Q35114519 | Herpes simplex virus infections of women and their offspring: implications for a developed society |
| Q35605299 | Herpes simplex virus-2 (HSV-2) type-specific antibody correlates of protection in infants exposed to HSV-2 at birth |
| Q45836593 | Impaired neonatal natural killer-cell activity to herpes simplex virus: decreased inhibition of viral replication and altered response to lymphokines |
| Q91909146 | Infecciones neonatales (II) |
| Q36341079 | Kinetics and genetics of herpes simplex virus-induced antibody formation in mice |
| Q93604737 | La prévention et la prise en charge des infections par le virus de l’herpès simplex |
| Q66680679 | Maternal immunization confers protection against neonatal herpes simplex mortality and behavioral morbidity |
| Q35545367 | Neonatal herpes simplex infection |
| Q33815811 | Neutralizing antibodies inhibit axonal spread of herpes simplex virus type 1 to epidermal cells in vitro |
| Q90196797 | Nucleoside-modified mRNA encoding HSV-2 glycoproteins C, D, and E prevents clinical and subclinical genital herpes |
| Q70191498 | Perinatal viral infections |
| Q33687109 | Prevalence of antibodies to herpes simplex virus types 1 and 2 in pregnant women, and estimated rates of infection |
| Q33640117 | Prevention and management of neonatal herpes simplex virus infections |
| Q40598225 | Role of antiviral antibodies in resistance against coxsackievirus B3 infection: interaction between preexisting antibodies and an interferon inducer |
| Q36765590 | The immunologic basis for severe neonatal herpes disease and potential strategies for therapeutic intervention |
| Q68105188 | Toward the rational management of herpes infection in pregnant women and their newborn infants. Infectious Diseases and Immunization Committee, Canadian Paediatric Society |
| Q90437526 | Trivalent glycoprotein subunit vaccine prevents neonatal herpes simplex virus mortality and morbidity |
| Q37424183 | Vertical transmission of genital herpes: prevention and treatment options |
Search more.